chronic inflammation

SILVER SPRING, Md., July 15, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...

COPENHAGEN, Denmark & NEW YORK, USA, July 15, 2026 HERVolution Therapeutics ApS, a biotechnology company developing human endogenous retrovirus...

VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...

VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...

VALENCIA, Calif., May 14, 2026 SetPoint Medical announced the publication of a peer-reviewed health economics study demonstrating that its...

INGELHEIM, Germany and WALTHAM, Mass., May 12, 2026 Boehringer Ingelheim has entered into a global licensing agreement with Immunitas...

SOUTH SAN FRANCISCO, Calif., May 7, 2026 TRexBio announced new late-breaking translational and preclinical data supporting TNFR2 agonism as...